Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Astra's new antiasthmatic, antirhinitic agents

Oct. 29, 1998

Latest preclinical data further supports antiasthmatic efficacy of betotastine besilate

Oct. 28, 1998

New antiasthmatic agent launched in Italy by Zeneca, Chiesi and Recordati

Oct. 27, 1998

FDA grants fast track status to Surfaxin in MAS

Oct. 26, 1998

Fournier characterizes potent and selective human bradykinin B2 antagonist in vitro

Oct. 23, 1998

Antiallergic/antiinflammatory compounds in development at Nikken Chemicals

Oct. 21, 1998

Phase II trial of tgAAV-CF completed, preliminary data presented at CF conference

Oct. 20, 1998

Positive phase I safety and efficacy results reported for INS-365

Oct. 20, 1998

Gene-based CF therapeutic developed by Megabios and Glaxo Wellcome proves safe in humans

Oct. 20, 1998

FDA awards fast track status and development grant to Surfaxin

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...